Intensive Care PatientsRelativesDelirium in the Intensive Care UnitSedativesFamily
Study summary
The aim of this prospective cohort study was to investigate the effect of the time spent with relatives of patients treated in a tertiary intensive care unit on patient outcomes.
The main question it aimed to answer was:
Does spending more time with relatives of patients in intensive care result in lower sedative agent requirements? Does spending more time with relatives of patients in intensive care result in less delirium, fewer ventilator days, and shorter ICU stays?
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients aged 18 and over.
* Patients with at least one family member actively involved in the care process in the ICU.
Exclusion Criteria:
* Patients with pre-existing cognitive impairment or dementia.
* Patients with severe traumatic brain injury.
* Patients with an expected mortality in the ICU of more than 80%.
* Absence of family members for patients admitted to the ICU.
Primary outcome measure(s)
Sedative dose — Each patient will be evaluated and recorded daily up to first 4 weeks of their stay in ICU. It is the average daily dose of sedative drugs used by a patient. It will be calculated for each sedative drug. It will be calculated by dividing all doses taken by the number of days of hospitalization.
Trial sites (1)
Facility
City
Region
Status
Cerrahpaşa Medical Faculty
Istanbul
Turkey (Türkiye)
Recruiting
More Istanbul University - Cerrahpasa trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.